Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 30, 2017

DrugPatentWatch Database Preview

AZTREONAM Drug Profile

« Back to Dashboard

Which patents cover Aztreonam, and what generic Aztreonam alternatives are available?

Aztreonam is a drug marketed by Fresenius Kabi Usa and West-ward Pharms Int and is included in two NDAs.

The generic ingredient in AZTREONAM is aztreonam. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the aztreonam profile page.

Summary for Tradename: AZTREONAM

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list41
Clinical Trials: see list15
Patent Applications: see list5,389
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AZTREONAM at DailyMed

Pharmacology for Tradename: AZTREONAM

Ingredient-typeMonobactams
Drug ClassMonobactam Antibacterial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa
AZTREONAM
aztreonam
INJECTABLE;INJECTION065439-002Jun 18, 2010APRXNoNo► Subscribe► Subscribe
West-ward Pharms Int
AZTREONAM
aztreonam
INJECTABLE;INJECTION065286-001Mar 23, 2011DISCNNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
AZTREONAM
aztreonam
INJECTABLE;INJECTION065439-003Jun 18, 2010APRXNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
AZTREONAM
aztreonam
INJECTABLE;INJECTION065439-001Jun 18, 2010RXNoNo► Subscribe► Subscribe
West-ward Pharms Int
AZTREONAM
aztreonam
INJECTABLE;INJECTION065286-002Mar 23, 2011DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Identify first generic entrants
  • Uncover prior art in abandoned patent applications and expired patents
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot